<html>

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=Generator content="Microsoft Word 15 (filtered)">
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:0cm;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
h1
	{mso-style-link:"Heading 1 Char";
	margin-top:12.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:16.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;
	font-weight:normal;}
h3
	{mso-style-link:"Heading 3 Char";
	margin-top:2.0pt;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:0cm;
	margin-bottom:.0001pt;
	line-height:107%;
	page-break-after:avoid;
	font-size:12.0pt;
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;
	font-weight:normal;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:0cm;
	margin-left:36.0pt;
	margin-bottom:.0001pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{margin-top:0cm;
	margin-right:0cm;
	margin-bottom:8.0pt;
	margin-left:36.0pt;
	line-height:107%;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-link:"Heading 1";
	font-family:"Calibri Light",sans-serif;
	color:#2F5496;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-link:"Heading 3";
	font-family:"Calibri Light",sans-serif;
	color:#1F3763;}
.MsoChpDefault
	{font-family:"Calibri",sans-serif;}
.MsoPapDefault
	{margin-bottom:8.0pt;
	line-height:107%;}
@page WordSection1
	{size:595.3pt 841.9pt;
	margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
	{page:WordSection1;}
 /* List Definitions */
 ol
	{margin-bottom:0cm;}
ul
	{margin-bottom:0cm;}
-->
</style>

</head>

<body lang=EN-AU>

<div class=WordSection1>

<h1><a name="_Hlk21366415"><span lang=EN-US style='font-size:15.0pt;line-height:
107%'>2014B03 Briefly outline the acute management of malignant hyperthermia
(during a relaxant general anaesthetic). <br>
Describe the important aspects of dantrolene pharmacology relevant to treating
malignant hyperthermia.</span></a></h1>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>List:</span></h3>

<p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Summary</span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Immediate Mx</span></p>

<p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
margin-bottom:0cm;margin-left:22.5pt;margin-bottom:.0001pt;text-indent:-13.5pt'><span
lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span><span lang=EN-US>Dantrolene pharmacology</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Summary:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Definition</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>Rare, life-threatening hypermetabolic reaction
  to volatile anaesthetics or suxamethonium</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Aetiology</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Autosomal
  dominant mutation RYR1 gene encoding the skeletal muscle ryanodine receptor
  (RR) and ion channel</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>1
  in 200,000</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Pathophysiology</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Continuous,
  excessive Ca<sup>2+</sup> release</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Continuous
  skeletal muscle contraction</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↑↑VO<sub>2</sub>,
  ↑↑VCO<sub>2</sub></span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>↑HR,
  ↑etCO<sub>2</sub>, ↑temp</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Complications</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Rhabdomyolysis</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Acidosis</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Arrhythmia</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Death
  (80% mortality if untreated)</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Immediate
treatment:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Basics</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Call
  for help, need many hands</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Abandon
  surgery</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Stop
  the offending agent(s) ASAP</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.5pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>Cease
  volatile, FGF &gt;10L/min to flush circuit, ↑FiO<sub>2</sub> to 100%</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.5pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>No more
  suxamethonium</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Start
  IV sedation e.g. propofol 30mL/h</span></p>
  </td>
 </tr>
 <tr style='height:50.35pt'>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt;height:50.35pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>ABC</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt;height:50.35pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>A:
  insert ETT</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>B:
  IPPV, note ↑↑MV required</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>C:
  ensure BP within safe limits, insert arterial line</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>D:
  sedate e.g.propofol 200mg/h</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Dantrolene ASAP</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Bolus
  dose: 2.5mg/kg rapidly </span><span lang=EN-US>±</span><span lang=EN-US>
  repeat; may require &gt;10mg/kg</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Infusion
  for up to 24h: 1mg/kg/h</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Cool to 37C</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Remove
  clothing and blankets</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Cold
  IV saline</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Cold
  bladder or intraperitoneal irrigation</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Treat complications</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraph style='margin-top:0cm;margin-right:0cm;margin-bottom:
  0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;line-height:
  normal'><span lang=EN-US style='font-family:Symbol'>·<span style='font:7.0pt "Times New Roman"'>&nbsp;
  </span></span><span lang=EN-US>e.g. hyperkalemia</span></p>
  </td>
 </tr>
 <tr>
  <td width=114 valign=top style='width:85.25pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Take to ICU</span></p>
  </td>
  <td width=717 valign=top style='width:538.05pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Observation
  ~24 hours</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>+/-
  dantrolene infusion</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<h3><span lang=EN-US style='font-size:13.0pt;line-height:107%'>Dantrolene
pharmacology:</span></h3>

<table class=MsoTableGrid border=1 cellspacing=0 cellpadding=0
 style='border-collapse:collapse;border:none'>
 <tr>
  <td width=125 valign=top style='width:93.8pt;border:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Physicochemical</span></p>
  </td>
  <td width=706 valign=top style='width:529.5pt;border:solid windowtext 1.0pt;
  border-left:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Glass
  vial, orange powder</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>20mg
  dantrolene, 3mg mannitol (solubiliser), NaOH</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Add
  to 60mL H<sub>2</sub>O</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Needs
  mixing +++ (poorly water soluble)</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>± </span><span
  lang=EN-US>thrombophlebitis</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>±</span><span
  lang=EN-US> necrosis if extravasated</span></p>
  </td>
 </tr>
 <tr>
  <td width=125 valign=top style='width:93.8pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Pharmacokinetic</span></p>
  </td>
  <td width=706 valign=top style='width:529.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>IV
  or oral</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Low
  V<sub>D</sub> 0.6L/kg</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>90%
  plasma protein bound</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Hepatic
  metabolism Phase 1; active metabolite 5-OH-dantrolene</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Renal
  excretion of metabolites</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>t<sub>1/2</sub></span><sub><span
  lang=EN-US>β</span></sub><span lang=EN-US> 9 hours</span></p>
  </td>
 </tr>
 <tr>
  <td width=125 valign=top style='width:93.8pt;border:solid windowtext 1.0pt;
  border-top:none;padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt;line-height:
  normal'><span lang=EN-US>Pharmacodynamic</span></p>
  </td>
  <td width=706 valign=top style='width:529.5pt;border-top:none;border-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  padding:0cm 5.4pt 0cm 5.4pt'>
  <p class=MsoListParagraphCxSpFirst style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Competitive
  antagonist at the skeletal muscle RR -&gt; ↓Ca<sup>2+</sup> release -&gt;
  post-junctional relaxation</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Effects:
  skeletal muscle relaxation, resp paralysis</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>No
  effect on cardiac or CNS ryanodine receptor</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:8.0pt;margin-bottom:.0001pt;text-indent:-8.0pt;
  line-height:normal'><span lang=EN-US style='font-family:Symbol'>·<span
  style='font:7.0pt "Times New Roman"'>&nbsp; </span></span><span lang=EN-US>Side
  effects rare:</span></p>
  <p class=MsoListParagraphCxSpMiddle style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.5pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>↑LFTs</span></p>
  <p class=MsoListParagraphCxSpLast style='margin-top:0cm;margin-right:0cm;
  margin-bottom:0cm;margin-left:30.5pt;margin-bottom:.0001pt;text-indent:-9.0pt;
  line-height:normal'><span lang=EN-US style='font-family:"Courier New"'>o<span
  style='font:7.0pt "Times New Roman"'> </span></span><span lang=EN-US>APO from
  IV fluid +++</span></p>
  </td>
 </tr>
</table>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><u><span
lang=EN-US><span style='text-decoration:none'>&nbsp;</span></span></u></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

<p class=MsoNormal style='margin-bottom:0cm;margin-bottom:.0001pt'><span
lang=EN-US>&nbsp;</span></p>

</div>

<p class="MsoNormal">Feedback welcome at <a href="mailto:ketaminenightmares@gmail.com">ketaminenightmares@gmail.com</a></p>
</body>

</html>
